Finance

Beta
Senarai
TLIK:FRA
Arzneiwerk VIDA AG
€0.21
+1.94%
(+0.0040) 1H
21 Jul, 12:36:13 PTG GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk TLIK...
Buka
€0.21
Tinggi
€0.21
Rendah
€0.21
Permodalan Pasaran
1.28J
Purata volum
79.00
Volum
7.00
tgi 52 mgu
€0.59
rdh 52 mgu
€0.00
EPS
-€0.09
Bilangan pekerja
1
Buka
€0.21
Tinggi
€0.21
Rendah
€0.21
Permodalan Pasaran
1.28J
Purata volum
79.00
Volum
7.00
tgi 52 mgu
€0.59
rdh 52 mgu
€0.00
EPS
-€0.09
Bilangan pekerja
1
Cerita berita
Daripada sumber merentas web
Profil
TELES AG Informationstechnologien is a provider of equipment and services to fixed, fixed-mobile convergence, and Next Generation Networking service providers. The company was founded in 1983 as TELES GmbH by Professor Dr.-Ing. Sigram Schindler in close cooperation with Technische Universität Berlin. Professor Schindler lectured in telecommunications at the university until 1998. In 1997, he was voted High-Tech Manager of the Year by Manager Magazine in Germany. Active in VoIP technology development since 1996, the company's main development and operational focus lies in the areas of IMS and NGN. TELES supplies service providers with complete Class 4 and Class 5 NGN Softswitch. TELES NGN is a standard based, scalable architecture aimed at minimizing integration time and allowing quick deployment. It includes hosted voice functionality which enables residential VoIP services, hosted PBX services, Fixed-Mobile-Convergence, IP Trunking, and additional value added applications. Classical NGN/PSTN applications like Wholesale, Long Distance, and NGN backbone services are also available with this. Wikipedia
Perihal Arzneiwerk VIDA AG
CEOOliver Olbrich
Pekerja1
Diasaskan1983
Ibu pejabat-
Sektor-
Laman webarzneiwerk.ag
Laporan sebelumnyaSemua nilai dalam EUR
Loading Previous Earnings...
Penyata pendapatan
Hasil
Pendapatan bersih
Semua nilai dalam EUR
Mac 2025
Jun 2025
Sep 2025
Dis 2025
Hasil
40.23K
28.22K
46.00
46.00
Kos barangan yang dijual
-
-
-
-
Kos hasil
-
-
-
-
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
25.63K
21.36K
20.86K
20.86K
Belanja kendalian
154.61K
266.00K
-13.70K
-13.70K
Jumlah belanja kendalian
154.61K
266.00K
-13.70K
-13.70K
Pendapatan kendalian
-114.38K
-237.78K
13.74K
13.74K
Pendapatan bukan kendalian lain
1.00
-2.00
-40.76K
-40.76K
EBT termasuk item luar biasa
-179.73K
-302.68K
-40.71K
-40.71K
EBT tidak termasuk item luar biasa
-179.73K
-302.68K
-58.06K
-58.06K
Belanja cukai pendapatan
-
-
-
-
Kadar cukai berkesan
-
-
-
-
Belanja kendalian lain
127.74K
244.08K
-34.87K
-34.87K
Pendapatan bersih
-179.73K
-302.68K
-40.71K
-40.71K
Margin untung bersih
-446.77%
-1,072.56%
-88,504.35%
-88,504.35%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
-
-
40.00
40.00
Belanja faedah
-65.35K
-64.90K
-31.08K
-31.08K
Belanja faedah bersih
-65.35K
-64.90K
-31.04K
-31.04K
Caj susut nilai dan pelunasan
1.24K
557.00
316.00
316.00
EBITDA
-113.14K
-237.22K
14.06K
14.06K
Keuntungan atau kerugian daripada jualan aset
-
7.98K
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian

Penyelidikan

Apakah perkara yang anda fikirkan?
Apakah yang berlaku dengan pasaran hari ini?
Terokai perkara yang boleh dilakukan
Buat portfolio
Buat tugasan
Deep Search
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian